BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2778375)

  • 1. [Response of human lymphocytes to phytohemagglutinin (PHA) as measured by fluorescence polarization technique--differences between malignant conditions and benign or healthy conditions].
    Tenzaki T; Ishiguro T
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):817-25. PubMed ID: 2778375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of lymphocyte stimulation by flow cytometry: differences in cells from patients with and without neoplasia.
    Hartmann W; Sackmann E; Eisert WG; Eisert R; Fliedner TM
    Biomedicine; 1980 Dec; 32(4):185-8. PubMed ID: 7470580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of cytoplasmic viscosity by fluorescence polarization in phytohemagglutinin-stimulated and unstimulated human peripheral lymphocytes.
    Hashimoto Y; Shinozaki N
    J Histochem Cytochem; 1988 Jun; 36(6):609-13. PubMed ID: 3367046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in the diagnosis of colorectal carcinoma.
    Hocking GR; Rolland JM; Nairn RC; Pihl E; Cuthbertson AM; Hughes ES; Johnson WR
    J Natl Cancer Inst; 1982 Apr; 68(4):579-83. PubMed ID: 6951073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
    Merimsky O; Kaplan B; Deutsch M; Tirosh R; Weinreb A; Chaitchik S
    Cancer Detect Prev; 1997; 21(2):167-77. PubMed ID: 9101078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction.
    Di Ianni M; Casciari C; Ciurnelli R; Fulvi A; Bagnis C; Lucheroni F; Falzetti F; Mannoni P; Martelli MF; Tabilio A
    Haematologica; 1996; 81(5):410-7. PubMed ID: 8952153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).
    Orjasaeter H; Jordfald G; Svendsen I
    Br J Cancer; 1979 Oct; 40(4):628-33. PubMed ID: 387060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in cancer and noncancer conditions.
    Rolland JM; Nairn RC; Nind AP; Pihl E
    J Natl Cancer Inst; 1984 Feb; 72(2):267-73. PubMed ID: 6319791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE receptors on human lymphocytes. III. Expression of IgE receptors on mitogen-stimulated human mononuclear cells.
    Delespesse G; Sarfati M; Rubio-Trujillo M; Wolowiec T
    Eur J Immunol; 1986 Sep; 16(9):1043-7. PubMed ID: 3019705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The trace and subgrouping of lymphocyte activation by dynamic fluorescence intensity and polarization measurements.
    Sunray M; Kaufman M; Zurgil N; Deutsch M
    Biochem Biophys Res Commun; 1999 Aug; 261(3):712-9. PubMed ID: 10441491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes in PHA and allogeneic reactivity of human T lymphocytes.
    Matej H; Myc A
    Arch Immunol Ther Exp (Warsz); 1983; 31(1):33-8. PubMed ID: 6604509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early effect of specific immunotherapy on lymphocyte response to PHA and allergens in atopic patients with allergic rhinitis.
    Kinikli G; Tülek N; Sentürk T; Turgay M; Tutkak H; Duman M; Tokgöz G
    Allergol Immunopathol (Madr); 1996; 24(2):65-9. PubMed ID: 8933891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between patients with malignant diseases and non-malignant diseases or healthy donors by changes of fluorescence polarization in the cytoplams of circulating lymphocytes.
    Hashimoto Y; Yamanaka T; Takaku F
    Gan; 1978 Apr; 69(2):145-9. PubMed ID: 680459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin-related and adherent cell suppressor system in apparently cured Hodgkin's disease patients.
    Haim N; Meidav A; Samuelly B; Segal R; Mekori T; Robinson E
    J Biol Response Mod; 1984; 3(2):219-25. PubMed ID: 6233397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competition of IL-1 and IL-1ra determines lymphocyte response to delayed stimulation with PHA.
    Dabrowski MP; Stankiewicz W; Płusa T; Chciałowski A; Szmigielski S
    Mediators Inflamm; 2001 Jun; 10(3):101-7. PubMed ID: 11545246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of lymphocytes in a patient with Wiskott-Aldrich syndrome: studies by fluorescence polarization.
    Shiotsuki K; Hirata T; Ota M; Kimura K; Hiyoshi Y; Yamashita F; Yokoyama MM
    J Clin Lab Immunol; 1989 Apr; 28(4):201-5. PubMed ID: 2628582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.
    Balding P; Light PA; Preece AW
    Br J Cancer; 1980 Jan; 41(1):73-85. PubMed ID: 6153900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phytohemagglutinin and interleukin-2 on malignant and nonmalignant B and T lymphocytes.
    Porwit A; Panayotides P; Wasserman J; Reizenstein P
    Cancer Detect Prev; 1988; 12(1-6):91-6. PubMed ID: 3263204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of mitogen responding lymphocytes by fluorescence polarization.
    Udkoff R; Chan S; Norman A
    Cytometry; 1981 Jan; 1(4):265-71. PubMed ID: 7021109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent decreases in mitogen-stimulation level and RNA content in peripheral blood mononuclear cells of Down syndrome patients.
    Hamurcu Z; Demirtas H; Patiroglu T; Kumandas S; Imamoglu N; Ozkul Y; Donmez-Altuntas H
    Cytometry B Clin Cytom; 2007 Jan; 72(1):43-8. PubMed ID: 17041944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.